What is "ataluren"

n. A novel small-molecular agent designed to make ribosomes become less sensitive to, or possibly ignore, premature stop codons.

Ataluren, formerly known as PTC124, is a pharmaceutical drug for the treatment of Duchenne muscular dystrophy and potentially other genetic disorders. It was designed by PTC Therapeutics and is sold under the trade name Translarna in the European Union.